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The PA200 proteasome activator is a broadly expressed nuclear protein. Although how PA200 normally functions
is not fully understood, it has been suggested to be involved in the repair of DNA double-strand breaks (DSBs). The
PA200 gene (Psme4) is composed of 45 coding exons spanning 108 kb on mouse chromosome 11. We generated a
PA200 null allele (PA200) through Cre-loxP-mediated interchromosomal recombination after targeting loxP sites
at either end of the locus. PA200/ mice are viable and have no obvious developmental abnormalities. Both
lymphocyte development and immunoglobulin class switching, which rely on the generation and repair of DNA
DSBs, are unperturbed in PA200/ mice. Additionally, PA200/ embryonic stem cells do not exhibit increased
sensitivity to either ionizing radiation or bleomycin. Thus, PA200 is not essential for the repair of DNA DSBs
generated in these settings. Notably, loss of PA200 led to a marked reduction in male, but not female, fertility. This
was due to defects in spermatogenesis observed in meiotic spermatocytes and during the maturation of postmeiotic
haploid spermatids. Thus, PA200 serves an important nonredundant function during spermatogenesis, suggesting
that the efficient generation of male gametes has distinct protein metabolic requirements.
The 20S proteasome, or core particle (CP), is a highly con-
served complex that mediates protein catabolism in the nucleus
and cytoplasm of all eukaryotic cells. The CP is cylindrical in
structure with a central channel formed by four heptameric rings,
two composed of  subunits sandwiched between two composed
of  subunits (8, 29). The  subunits have active sites, positioned
towards the inside of the channel, that mediate indiscriminate
protein degradation (8, 29). The -rings serve as gatekeepers,
preventing proteins from inadvertently gaining access to the cen-
tral channel of the CP, where they would be degraded (8, 29).
Access to the CP channel is regulated by proteasome acti-
vators that associate with the  heptameric rings at either end
of the CP. There are four known proteasome activators,
PA700/19S, PA28/, PA28, and PA200, that are broadly
expressed in mammalian cells (1, 8, 33, 37, 42, 43). The 19S
proteasome activator, also referred to as the regulatory parti-
cle (RP), is composed of approximately 20 subunits and asso-
ciates with the CP in an ATP-dependent manner. Capping of
the CP at one or both ends by the 19S proteasome activator
leads to formation of the 26S proteasome, which degrades
ubiquitinylated proteins. The remaining proteasome activa-
tors, PA28/, PA28, and PA200, associate with the CP in an
ATP-independent manner and stimulate the degradation of
peptides, but not whole proteins, in vitro. Notably, the CP can
be capped at either end by different proteasome activators,
forming hybrid complexes (16, 36, 41).
PA28 and PA28 combine to form PA28/ hetero-hex-
americ or hetero-heptameric rings (39, 45). PA28 and PA28
expression is induced by gamma interferon, and the PA28/
activator has been implicated in regulating the function of the
immunoproteasome, a variant of the 20S proteasome that en-
hances the generation of antigenic peptides for presentation
to T lymphocytes during immune responses (20). PA28 and
PA28 are encoded by relatively small genes (Psme1 and
Psme2, respectively) that are closely linked on mouse chro-
mosome 14 (21). Mice with complete deletions of both the
PA28 and PA28 genes have normal immunoproteasome
levels and selective defects in the generation and presenta-
tion of antigenic peptides (26).
PA28 homopolymers of six or seven subunits also form a
proteasome activator that binds the -ring of the CP (42).
Unlike the 19S and PA28/ activators, which are distributed
throughout the cell, PA28 appears to be localized primarily to
the nucleus (40, 44). PA28-deficient mice have a slight reduc-
tion in body weight, and PA28-deficient fibroblasts exhibit
mild cell cycle progression defects not observed in proliferating
PA28-deficient lymphocytes (5, 25). PA28-deficient mice
have lower numbers of CD8 T cells and have a diminished
capacity to clear some pathogens, possibly reflecting defects in
antigen processing (5).
The PA200 proteasome activator is a 200-kDa protein local-
ized primarily to the nucleus (27, 43). PA200 is broadly ex-
pressed in mammalian tissues, existing at the highest levels in
testes (43). Although PA200 is distributed throughout the nu-
cleoplasm, it forms discrete foci in mammalian cells upon ex-
posure to ionizing radiation, suggesting that it may be involved
in DNA double-strand break (DSB) repair (43). Studies in
Saccharomyces cerevisiae have demonstrated that proteasomes
localize to the sites of DNA DSBs and function in their repair
(23). Whether PA200 serves an active role in DSB repair or
simply localizes to DSBs with the proteasome is not known.
Recent studies of the yeast PA200 ortholog Blm10 (previously
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called Blm3), revealed that it binds the CP as a single ring-
shaped polypeptide chain and can participate in the formation
of hybrid complexes with the 19S activator (36). Yeast with
Blm10 null mutations exhibit only a mild increase in sensitivity
to the radiomimetic drug bleomycin (36). However, yeast ex-
pressing a C-terminal-truncated version of Blm10 exhibit a
significant increase in bleomycin sensitivity (36). Thus, if and
how PA200 and Blm10 function in the repair of DNA DSBs
remain open questions.
In addition to the responses to genotoxic agents such as
ionizing radiation and bleomycin, DNA DSBs are also gener-
ated under physiologic conditions. In this regard, DNA DSBs
are generated during antigen receptor gene assembly in devel-
oping B and T lymphocytes and during immunoglobulin class
switch recombination in mature B cells (6, 9, 14). Mice defi-
cient in proteins required to repair these DSBs exhibit pro-
found defects in lymphocyte development and/or defects in
immunoglobulin class switch recombination (6, 9). In addition,
DNA DSBs are generated during meiosis, and successful ga-
metogenesis depends upon the repair of these DSBs (7, 12,
31). Thus, if PA200 is involved in the repair of DNA DSBs, its
absence could impact any, or all, of these processes.
Here we have generated and analyzed PA200 null mice. The
PA200 gene (Psme4) lies on mouse chromosome 11 and is
composed of 48 exons spanning 108 kb. The PA200 allele was
generated by Cre-mediated recombination after the sequential
targeting of loxP sites at the 5 and 3 ends of the PA200 gene.
PA200/ cell lines do not exhibit increased sensitivity to either
bleomycin or ionizing irradiation, and PA200/ mice do not
exhibit measurable lymphocyte developmental defects sugges-
tive of a significant DNA DSB repair defect. However, al-
though PA200/ females exhibited normal fertility, PA200/
males exhibit a marked reduction in fertility due to pre- and
postmeiotic defects in spermatogenesis. Our findings establish
a critical and nonredundant function for the PA200 protea-
some activator during spermatogenesis.
MATERIALS AND METHODS
Generating PA200 targeting constructs. pPA2005LoxP.Neo was generated by clon-
ing the 5 homology arm (2.5-kb HindIII fragment from a PCR product generated
with I15.03 [GCTTGCTCAGGGTGCT] and I15.04 [TTGTTAGTTGTCAGGCT
CA]) and the 3 homology arm (2.4-kb PCR product generated with I16.08 [CCC
ATCGATATGTTGTCCATACTAACTAAGC] and I16.11 [CGGGATCCTA
AAAAGACTATCCTCCTAGTTT]) into pLNTK (10). pPA2003LoxP.Neo was gen-
erated by cloning the 5 homology arm (6.0-kb EcoRV-ClaI fragment from a PCR
product generated using I26.03 [ACTTAATAGAAAACCATGCTGTGAC] and
I29.02 [CCGCTCGAGGGCAGTACAGTCTTACTCAA]) and the 3 homology
arm (2.4-kb ClaI-HindIII fragment from a PCR product generated with I26.05
[TACACTTCAAATGAGTGGAA] and I26.06 [GGATGCTCCAATATAAGAA
A]) into pLNTK.
ES cell culture. 129/B6 embryonic stem (ES) cells, used for initial gene tar-
getings, were cultured, transfected, and selected as previously described (17). Cre
deletions were carried out in vitro using a Cre-expressing adenoviral vector as
previously described (17). PA200/ and PA200/ ES cells were derived
through intercrossing PA200/ mice as previously described (19). For ionizing
radiation and bleomycin sensitivity assays, ES cells were plated at various cell
numbers 12 h prior to ionizing radiation or incubation in medium containing
bleomycin as previously described (35). ES cells were incubated in the indicated
concentration of bleomycin for 72 h. At day 7 of culture, cell colonies were
counted after staining with 1% crystal violet.
Southern and Northern blot analyses. Genomic DNA and whole-cell RNA
were isolated and prepared for Southern and Northern blotting, respectively, as
previously described (17). The probes used were generated by PCR using the
following primer pairs: P1, a 0.5-kb ScaI-KpnI fragment of the PCR product
generated with I15.01 (CCACTTCTGTGTTTGCCA) and I15.02 (TGGAACA
CAGATTACGGGAA); P2, a 1.6-kb PCR product generated with I16.01 (CA
CTCCAGAACCAAGACT) and I16.02 (GATGTCTCCCCAGTGC); P3, a
2.5-kb EcoRV fragment of the PCR product generated with I26.03 and I26.04
(TTCCATCTCCATCTTGGTAG); P4, a 3.2-kb PCR product generated with
I26.07 (CATGATCTTGAACCTGTCTT) and I26.08 (TCCTATTTTAAGTCT
CTTAGTGT). The PA200 cDNA probe is a 1.2-kb XbaI fragment. The c-myc
probe used was a 0.7-kb cDNA fragment generated by PCR with C-MYC-F
(AGCAACAGCAGAG) and C-MYC-R (ACAGACACCACATCAATTTC).
Generation of anti-PA200 antiserum and Western blotting. Anti-PA200 rabbit
antiserum was generated by Quality Controlled Biochemicals (Hopkinton, MA)
through immunization and boosting of rabbits with a PA200 N-terminal peptide
(RLPNSVVRRLHRERFKKPC) linked to keyhole limpet hemocyanin. To ob-
tain whole ES cell lysate for Western blotting, ES cells were resuspended in 1
Laemmli sample buffer, boiled for 5 min, and sonicated. Testes lysate was
prepared by homogenizing (Omni tissue homogenizer) in five volumes of S1
buffer (200 mM dithiothreitol, 120 mM Tris-HCl, pH 6.8, 10% protease inhibitor
[Sigma]). Sodium dodecyl sulfate (Invitrogen) and bromophenol blue (Mallinck-
rodt) were added at final concentrations of 2% and 0.1%, respectively. Samples
were run on a 10% polyacrylamide Criterion gel system (Bio-Rad) and trans-
ferred to an Immobilon-P polyvinylidene difluoride membrane (Millipore). Rab-
bit anti-PA200 serum (batch 7523) was diluted 1:500 into phosphate-buffered
saline–0.05% Tween (TPBS)–1% ovalbumin and detected with horseradish per-
oxidase-conjugated donkey anti-rabbit F(ab)2 (Amersham) diluted 1:5,000 into
TPBS–1% ovalbumin and ECL detection reagents (Amersham).
Flow cytometric analyses. Flow cytometric analyses were performed as previ-
ously described using a FACScalibur (Becton Dickinson) (17). Antibodies used
were phycoerythrin-conjugated anti-CD4, fluorescein isothiocyanate-conjugated
anti-CD8, phycoerythrin-conjugated anti-Thy1.2, and fluorescein isothiocyanate-
conjugated anti-B220 (Pharmingen).
Immunoglobulin ELISA analyses. Splenic B cells were purified by depletion of
T cells with anti-Thy1.2 magnetic beads (Dynal Biotech) and spun over Lym-
pholyte medium (Cedarlane). Purified B cells were determined to be 90%
B220 by fluorescence-activated cell sorting. B cells were stimulated at 105
cells/ml with medium containing 30 	g/ml lipopolysaccharide (LPS) with or
without 100 ng/ml interleukin-4 (IL-4), and supernatants were harvested at day
6. Total immunoglobulin (Ig) of diluted supernatants was captured with goat
anti-mouse Ig (Southern Biotechnology) adsorbed onto Maxisorp plates (Nunc).
Horseradish peroxidase-conjugated goat anti-mouse 1 (Southern Biotechnol-
ogy) was used to detect IgG1. Enzyme-linked immunosorbent assays (ELISAs)
were developed with H2O2-activated 2,2-azinobis(3-ethylbenzthiazoline), the
optical density at 405 nm was measured, and antibody titer was determined by
comparison to standard curves generated with known amounts of IgG1 (South-
ern Biotechnology).
Histologic analysis. PA200/ and PA200/ male mice were fixed with 1%
glutaraldehyde by perfusion prior to removal of testes and epididymides, which
were embedded in epoxy resin, sectioned, and stained with toluidine blue prior
to light microscopic analyses.
RESULTS
Generation of the PA200 allele through loxP targeting and
Cre-mediated recombination. The murine PA200 is a 1,869-
amino-acid protein encoded by a gene composed of 45 coding
exons spanning 108 kb. Thus, it is unlikely that a single gene
targeting could remove a significant portion of the gene.
Hence, we chose to delete the majority of the PA200 gene by
targeting loxP sites at the 5 and 3 ends of the locus followed
by Cre-mediated recombination between the two loxP sites.
The loxP-flanked neomycin resistance gene was inserted im-
mediately upstream of exon 2 (generating the PA2005loxP.Neo
allele) using the pPA2005loxP.Neo targeting vector (Fig. 1A).
The PA2005loxP allele was generated from the PA2005loxP.Neo
allele through Cre-mediated deletion of the neomycin resis-
tance gene (Fig. 1A). The PA2005loxP allele differs from the
wild-type PA200 allele only by the insertion of a single loxP site
upstream of exon 2 (Fig. 1A).
The pPA2003loxP.Neo targeting vector was used to target the
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loxP-flanked neomycin resistance gene downstream of PA200
exon 48 in the PA2005loxP/ ES cell line, and two targeted ES
cell lines were obtained (Fig. 1B). In these cell lines the loxP-
flanked neomycin resistance gene could lie in cis, 90 kb down-
stream of the 5 loxP site, on the same chromosome 11. Alter-
natively, the 5 loxP site and the loxP-flanked neomycin
resistance gene could lie in trans on separate chromosomes 11.
Expression of the Cre recombinase in the two ES cell lines
readily resulted in clones in which the neomycin resistance
gene was deleted (Fig. 1B). However, only one clone (PA200-
227) was obtained that appeared to have deleted the entire
PA200 gene through Cre-mediated recombination (Fig. 1C,
PA200).
This low frequency could result from the 5 loxP site being in
trans with the loxP-flanked neomycin resistance gene. If this
were the case, the PA200 allele would have been generated
through Cre-loxP-mediated interchromosomal recombination
between the maternal and paternal chromosomes 11, and this
ES cell should contain the reciprocal product of this unequal
interchromosomal recombination (Fig. 1C, PA200RP) (46). In-
deed, Southern blot analysis of the PA200-227 ES cell line
revealed the presence of both the PA200 and the PA200RP
alleles (Fig. 1C). Thus, the PA200 allele was generated
through a Cre-loxP-mediated interchromosomal recombina-
tion (Fig. 1C). PCR and sequence analyses revealed that this
recombination was precise without any alterations of the re-
gions flanking the loxP sites (data not shown). The PA200
allele contains only the first coding exon, which could, at most,
encode the N-terminal 80 amino acids of the 1,869-amino-acid
PA200 protein.
PA200/ embryos are viable and born at Mendelian ratios.
Germ line transmission of the PA200 allele was achieved
from chimeric mice generated from the PA200-227 ES cell
line. Intercrossing of PA200/ mice yielded near-Mendelian
ratios of PA200/ (26%), PA200/ (46%), and PA200/
(29%) offspring (Table 1). There were no overt differences in
the appearance or size of neonatal and adult PA200/,
PA200/, and PA200/ mice (data not shown). Northern blot
TABLE 1. Number of PA200/, PA200/, and PA200/ offspring
from intercrosses of PA2000/ males and females
Offspring No. (%)
PA200/........................................................................................ 41 (26)
PA200/ ........................................................................................ 74 (46)
PA200/......................................................................................... 46 (29)
Total................................................................................................161
FIG. 1. Generation of the PA200 allele. A and B. Schematic of the murine PA200 locus, drawn approximately to scale. The targeting
constructs pPA2005LoxP.Neo and pPA2003LoxP.Neo are shown, with relevant features indicated, including the neomycin resistance gene (N), flanking
loxP sites (open ovals), and thymidine kinase gene (TK). Relevant endogenous and introduced (*) BamHI (B and B*) and HindIII (H and H*)
sites are shown. Also shown are schematics of the targeted alleles before (PA2005LoxP.Neo and PA2003LoxP.Neo) and after (PA2005LoxP and
PA2003LoxP) Cre deletion of the neomycin resistance gene. The relative positions of the P1, P2, and P3 probes are shown along with Southern blot
analyses of either BamHI- (B) or HindIII- (H) digested ES cell genomic DNA. The bands representing the different targetings are indicated with
arrows. The BamHI P3-hybridizing bands from the PA200 and PA2003LoxP.Neo alleles are of similar size and are indicated with a single arrow.
DNA molecular mass markers (in kb) are also indicated. C. Schematic of Cre-mediated recombination between the PA2005LoxP and PA2003LoxP
alleles, generating the PA200 and PA200RP alleles through a chromosomal translocation. Southern blot analyses of EcoRV (V)-digested ES cell
genomic DNA probed with P1 and P3 are shown. The bands generated by the PA200 () and PA200RP (RP) alleles in the PA200-227 (227) ES
cell line are indicated.
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analysis of PA200/ ES cells (see below) did not reveal any
PA200 hybridizing mRNA (Fig. 2A). Moreover, we generated
a rabbit antiserum to an N-terminal PA200 peptide, and West-
ern blot analysis of whole-cell lysates from PA200/ ES cells
and PA200/ testes using this antiserum failed to reveal any
PA200 protein (Fig. 2B). Together, these data demonstrate
that PA200 deficiency does not lead to significant defects in
either embryonic development or viability of adult mice.
Development of PA200/ lymphocytes. Flow cytometric
analyses of thymocytes from PA200/ mice did not reveal
obvious defects in T-cell development (Fig. 3A and Table 2).
In this regard, PA200/ and PA200/ mice had similar num-
bers of CD4
 CD8
 (double-negative) pro-T cells, CD4
CD8 (double-positive) pre-T cells, and normal numbers of
CD4 and CD8 (single-positive) mature T cells in the thymus
(Fig. 3A; Table 2). Furthermore, flow cytometric analyses re-
vealed similar numbers of mature CD4 and CD8 splenic T
cells in PA200/ and PA200/ mice (Fig. 3B; Table 2). Fi-
nally, similar fractions of developing IgM
 (pro-B and pre-B)
and IgM (immature and mature B) cells were found in the
bone marrow of both PA200/ and PA200/ mice, and anal-
yses of splenocytes revealed similar fractions of mature B220
B cells (Fig. 3C and Table 2).
It is possible that PA200/ mice could have subtle defects in
lymphocyte development not detectable in the analyses above.
Such subtle defects have been revealed through the analysis of
mutant and wild-type lymphocytes developing in a competitive
fashion in the same host (2). To this end, we generated mixed
bone marrow chimera mice using equal numbers of PA200/
and PA200/ bone marrow cells. Analysis of these chimeric
mice revealed no differences in the development of PA200/
and PA200/ B and T cells (data not shown).
To assess immunoglobulin class switch recombination,
PA200/ and PA200/ B cells were stimulated in vitro with
either LPS and IL-4, which stimulate switching from IgM to
IgG1, or LPS alone, which does not. Both PA200/ and
PA200/ B cells exhibited similarly robust production of IgG1
when stimulated with LPS and IL-4 but not when stimulated
with LPS alone, demonstrating that PA200/ B cells can un-
dergo immunoglobulin class switch recombination (Fig. 3D).
PA200/ ES cells do not exhibit increased sensitivity to
ionizing radiation or bleomycin. To determine whether
PA200 deficiency leads to defects in the repair of DNA
DSBs generated by genotoxic agents, PA200/ and
FIG. 2. PA200 mRNA and protein are not detected in PA200/
cells. A. Northern blot analyses of mRNA from PA200/, PA200/,
and PA200/ ES cells using a PA200 cDNA probe and a c-myc probe
as an RNA loading control. B. Western blot analyses of total cell
lysates from PA200/ and PA200/ ES cells and testes using an
anti-PA200 antibody and an anti-Erk2 antibody as a protein loading
control.
FIG. 3. Lymphocyte development and immunoglobulin class switch recombination in PA200/ mice. A, B, and C. Flow cytometric analyses of
thymocytes (A) and splenocytes (B and C) from PA200/ and PA200/ mice using either anti-CD4 and anti-CD8 (A and B) or anti-Thy1.2 and
anti-B220 (C) antibodies. Gates and percentages are shown. D. Concentration of IgG1 in the supernatant of purified PA200/ (filled bars) and
PA200/ (open bars) B cells stimulated with either LPS or LPS plus IL-4. IgG1 concentrations were determined by ELISA. The mean
concentrations and standard deviations from two experiments are shown.
3002 KHOR ET AL. MOL. CELL. BIOL.
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PA200/ ES cell lines were assayed for sensitivity to ioniz-
ing radiation and bleomycin as described in Materials and
Methods. Three PA200/ (X15-1, 
4, and 
8) and three
PA200/ (X16-A1, -B3, and -B4) ES cell lines were generated
through the intercrossing of PA200/ mice as previously de-
scribed (19). Thus, the PA200/ and PA200/ ES cell lines
tested were of comparable genetic background and had been
cultured for similar periods of time before being tested. The
50% lethal doses (LD50s) for ionizing radiation of the three
PA200/ and PA200/ ES cell lines were not significantly dif-
ferent (Table 3). Moreover, the LD50 doses for bleomycin treat-
ment were also similar in the PA200/ and PA200/ ES cell
lines (Table 3). In contrast, the LD50s for ionizing radiation
and bleomycin treatment of cells deficient in XRCC4, an
NHEJ protein required for DNA DSB repair, were about half
of those observed for the PA200/ ES cells, consistent with
previous reports (Table 3) (15). Thus, PA200 is not essential
for the repair of DNA DSBs generated in ES cell lines upon
treatment with ionizing radiation or bleomycin.
Loss of PA200 does not increase the mortality of p53-defi-
cient mice. PA200/ mice do not exhibit significant survival
differences compared to wild-type mice (data not shown). Mice
deficient in p53 have increased tumor formation and decreased
survival due to genomic instability (18). Coupling p53 defi-
ciency with a DNA DSB repair defect often further increases
genomic instability, accelerates tumor formation, and de-





 PA200/ mice revealed no significant
differences in survival (Fig. 4). Thus, mice with a compound
loss of both PA200 and p53 do not exhibit decreased survival
compared to mice with an isolated loss of p53.
Defective spermatogenesis in PA200/ mice. Initial at-
tempts to breed PA200/ males yielded few offspring, whereas
PA200/ males yielded litters of relatively normal size at an
approximately normal frequency (data not shown). Three 12-
week-old PA200/ and three 12-week-old PA200/ male
mice were each bred to two PA200/ females for 11 weeks,
and the numbers of litters and offspring were monitored. Dur-
ing this period, the PA200/ males produced 14 litters with a
total of 119 pups, whereas the PA200/ males had only 6
litters with a total of 30 pups. Copulatory plugs were generated
on a regular basis by PA200/ males, suggesting that the
reduced number of offspring was not due to a copulatory de-
fect (data not shown). Light microscopic analysis of semen
isolated from the epididymides of PA200/ males revealed a
general decrease in the level of mature spermatozoa (data not
shown). In addition, many of the spermatozoa present were
malformed and exhibited motility defects (data not shown).
Together, these findings suggested that PA200/ males have a
defect in spermatogenesis.
Mouse spermatogenesis is a highly ordered process that
occurs in the seminiferous tubules of the testes, taking 34.5
days to complete (11). The stem cells, or spermatogonia, lie in
the periphery of the seminiferous tubule and divide mitotically
(11). Once cells enter meiosis, they are referred to as sper-
matocytes and, after completing the second meiotic division,
they become round haploid spermatids. Spermatids undergo a
series of morphological changes, collectively referred to as
spermiation, leading to the formation of mature spermatozoa.
These morphological changes include the generation of the
acrosome and tail, reorganization of the mitochondria, and
loss of most of the cytoplasm as a residual body. Spermato-
genesis occurs in waves across the length of the seminiferous
tubule, with new waves starting before maturation of the pre-
vious wave is complete. Consequently, cells at several stages of
TABLE 2. Thymocytes, bone marrow B-cell precursors, and mature splenic B and T cells in PA200/ and PA200/ 6-week-old micea
Mice (n)
Thymus Bone marrow Spleen









/ (3) 10  1 239  44 29  5 8  1 4.5  1.2 0.8  0.2 2.1  0.7 15  2 5  2 56  9
/ (3) 11  6 279  123 28  11 7  3 5.4  1.4 1.4  0.9 3.7  1.0 20  10 8  4 85  40
a Shown are the mean numbers of CD4
 CD8
 (double negative DN), CD4 CD8 (double positive DP), and CD4 and CD8 single positive (SP) thymocytes.
Also shown are the mean  standard deviation numbers of B220low IgM
, B220low IgM, and B220high IgM cells per femur. Finally, the mean  standard deviation
(10
6) numbers of splenic CD4 and CD8 T cells and B220 B cells are shown.
TABLE 3. Sensitivity of PA200/, PA200/, and XRCC4
/

ES cell lines to irradiation and bleomycin treatmenta
Treatment
LD50
PA200/ ES cell lines PA200/ ES cell lines XRCC4
/

cellsX15-1 X15-4 X15-8 X16-A1 X16-B3 X16-B4
Bleomycin
(ng/ml)
36  1 51  12 55  3 56  8 40  8 47  8 21  1
X-ray (cGy) 87  12 80  14 99  11 98  8 69  10 76  10 38  10
a Shown is the mean dose at which 50% of the plated cells survived (LD50) 
the standard deviation for the three experiments performed.
FIG. 4. Kaplan-Meier survival curves for PA200/ p53
/
 (filled
diamonds; n  21) and PA200/ p53
/
 (open squares; n  14) mice.
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FIG. 5. Histology of PA200/ testes and epidydimides. A. Low magnification of testes (plates A and B; bar, 100 	m) and epididymis (plates
C and D; bar, 50 	m) from 5-month-old PA200/ (wild type [WT]; plates A and C) and PA200/ (plates B and E) mice. Areas showing
vacuolation, multinucleated giant germ cells, and hypospermatocytogenesis are indicated (plate B, circles). Immature germ cells in the PA200/
caput epididymis are indicated (plate D, arrows). B. Seminiferous tubules from PA200/ (WT; plates A and B) and PA200/ (/; plates C to
H) mice. Bar, 50 	m. Histologic stages of development are indicated with roman numerals. Stages of spermatid maturation are indicated with
Arabic numbers. Also indicated are pachytene (P) and leptotene (L) spermatocytes, Sertoli cells (Sc), B-type spermatogonia (B), areas of
vacuolation (V), and residual bodies (Rb). The arrows indicate residual bodies (plates C and E), apoptotic and necrotic pachytene spermatocytes
(plates D and F), and spermatid phagocytosis (plate G). The asterisk indicates abnormal spermatids (plate C) and abnormal pachetyne
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sperm development can be observed at any location of the
seminiferous tubule. This heterogeneity in development across
the length of the seminiferous tubule allows for the discrimi-
nation of 12 histologic stages (I through XII) in mice (11).
Histologic analysis of PA200/ testes revealed multiple de-
fects in spermatogenesis (Fig. 5). PA200/ testes have focal
areas of abnormal spermatogenesis showing vacuolation,
multinucleated giant germ cells, and hypospermatocytogenesis
(Fig. 5A, plate B). Evaluation of epididymal lumens from
PA200/ males revealed a low concentration of normal ma-
ture spermatozoa and the presence of immature germ cells not
seen in epididymides of PA200/ males (Fig. 5A, plates C and
D). More-detailed histologic analyses of PA200/ testes re-
vealed normally appearing spermatagonia; however, significant
defects were noted in both meiotic spermatocytes and post-
meiotic spermatids (Fig. 5B). Numerous abnormal pachytene
spermatocytes (Fig. 5B, plates C, E and H) and apoptotic or
necrotic pachytene spermatocytes (Fig. 5B, plates D and F)
were noted in several stages of spermatogenesis. Defects in
spermiation were also evidenced by reduced numbers of sper-
matids, abnormal-appearing spermatids (Fig. 5B, plates C and
H), spermatid phagocytosis (Fig. 5B, plate G), and the accu-
mulation of residual bodies (Fig. 5B, plate E) in PA200/
testes.
To assess the extent of apoptosis in PA200/ testes, termi-
nal deoxynucleotidyltransferase-mediated dUTP-biotin nick
end labeling (TUNEL) staining was carried out (Fig. 6). These
analyses revealed an overall increase in the average number of
apoptotic TUNEL-positive cells per seminiferous tubule sec-
tion in PA200/ testes (Fig. 6A). Notably, there was signifi-
cant variation in the number of TUNEL-positive cells in dif-
ferent PA200/ tubule sections, suggesting that apoptosis is
more pronounced at specific stages of development (Fig. 6B).
Together, these findings demonstrate that PA200 deficiency
leads to defective spermatogenesis with histological abnormal-
ities observed in both meiotic spermatocytes and during the
maturation of postmeiotic haploid spermatids.
DISCUSSION
Generating true null alleles through a single gene-targeting
step poses challenges for genes with many exons spanning large
genomic regions, such as the PA200 gene. The importance of
generating a PA200 null allele in establishing the true function
of PA200 is underscored by the observation that yeast express-
ing a C-terminal-truncated version of Blm10, the PA200 or-
tholog, exhibit bleomycin sensitivity, whereas true Blm10 null
mutants do not (36). Here we have generated a PA200 null
allele (PA200) through a gene-targeting approach involving
Cre-mediated recombination between loxP sites introduced at
either end of the PA200 gene. Notably, the two loxP sites were
introduced in trans on separate chromosomes 11, with the
PA200 allele being generated through Cre-loxP-mediated in-
terchromosomal recombination. Thus, a Cre-loxP-mediated
recombination approach can be used to generate null alleles by
removing large regions of a gene, whether the loxP sites at
either end of the gene lie in cis or trans.
Analysis of PA200-deficient mice and cells revealed little
evidence to support the notion that PA200 is essential for the
repair of DNA DSBs generated either by genotoxic agents or
under physiologic conditions. In this regard, PA200/ and
PA200/ ES cells exhibit similar sensitivity to ionizing radia-
tion and bleomycin. Mice with deficiencies in proteins involved
in DNA DSB repair often exhibit increased genomic instability
and decreased survival when they have a compound deficiency
of the cell cycle checkpoint protein p53. However, mice with a
compound deficiency of PA200 and p53 do not exhibit dimin-
ished survival compared to those with an isolated deficiency of
p53. Lymphocyte development, which depends on the genera-
tion and repair of DNA DSBs, also appear unperturbed in
PA200/ mice, and PA200/ B cells undergo efficient immu-
noglobulin class switch recombination. Finally, although male
PA200/ mice exhibit fertility defects, it is unlikely that the
defects are solely attributable to a requirement for PA200 in
the repair of DNA DSBs generated during meiosis (see be-
low). Nevertheless, it is possible that PA200 could have
FIG. 6. Increased apoptotic cells in PA200/ testes. A. Mean  standard deviation number of TUNEL-positive cells per seminiferous tubule
section in PA200/ (open bar; n  2) and PA200/ (filled bar; n  4) mice. A minimum of 125 seminiferous tubule sections was counted from
each mouse. B. TUNEL staining of testes sections from PA200/ and PA200/ mice. Shown are the sections containing the seminiferous tubule,
with the greatest number of TUNEL-positive cells from / and / mice.
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subtle activities in DNA DSB repair not detected by the
parameters assessed here in the PA200-deficient mice. In
addition, other proteins, such as the nuclear PA28 protea-
some activator, could compensate for PA200 function in
PA200-deficient mice (40).
Unexpectedly, PA200/ males had significantly impaired
fertility due to a decreased production of normal spermatozoa,
demonstrating that PA200 serves a critical function in sper-
matogenesis. DNA DSBs are normally generated and repaired
during the first meiotic division of male and female gameto-
genesis. In this regard, deficiency of Dmc1 or Msh5, which are
required for the repair of DSBs generated during meiosis,
leads to both male and female sterility (13, 31). The apoptotic
pachytene spermatocytes in PA200/ testes could reflect a
requirement for PA200 in the repair of DNA DSBs generated
in these meiotic spermatocytes. However, any such require-
ment would not be generally applicable to all meiotic cells, as
PA200/ females did not exhibit fertility defects. In addition,
Dmc1- and Msh5-deficient male mice have a complete block at
the spermatocyte stage (13, 31). In contrast, spermatogenesis
proceeds beyond this stage in PA200/ mice with defects in
spermatid maturation that cannot be easily attributed to de-
fects in meiotic DNA DSB repair. Thus, the defects in sper-
matogenesis observed in PA200/ males cannot be due solely
to a requirement for PA200 in the repair of DNA DSBs gen-
erated in meiotic cells.
How then might PA200 function during spermatogenesis?
The requirement for PA200 could be intrinsic and/or extrinsic
to developing spermatocytes. Extrinsic requirements could re-
flect, for example, a role for PA200 in the normal function of
cells that support spermatogenesis, such as Sertoli cells. In this
regard, the accumulation of residual bodies in PA200-deficient
testes are consistent with a Sertoli cell dysfunction, as these
cells normally clear discarded residual bodies. However, Ser-
toli cell function can also be compromised by the release of
toxic compounds, such as protamine, from dying spermatids
which are present at increased levels in PA200/ testes (28).
The defects in spermiation in PA200/ mice demonstrate
that PA200 is required for the development of postmeiotic
spermatids. In this regard, developing spermatids undergo dra-
matic morphological and biochemical changes marked notably
by a change in the composition of DNA-associated proteins
throughout maturation. DNA-associated histone proteins are
initially removed and replaced with the transitional proteins,
TP1 and TP2, as spermatocytes become haploid spermatids
(3). These transition proteins must then be removed and re-
placed with protamine, permitting packaging of the DNA in
the confined space of the acrosomal head. Notably, distur-
bances in transition protein expression and metabolism lead to
abnormal spermatogenesis and diminished fertility (30, 38).
Thus, the defect in spermatid maturation in PA200/ mice
could, among other things, reflect a requirement for PA200 in
the metabolism of DNA-associated proteins.
Several lines of evidence implicate the ubiquitin-proteasome
system in the metabolism of DNA-associated proteins during
spermatogenesis. Ubiquitin is found in high levels in the testes,
and during mouse spermatogenesis H2A, a major histone pro-
tein, is highly ubiquitinylated in spermatocytes just prior to its
replacement with transition proteins (4, 24). Moreover, expres-
sion of the HR6B ubiquitin-conjugating enzyme is upregulated
in spermatocytes (22). Interestingly, HR6B-deficient mice have
an isolated defect in male fertility similar to that observed in
PA200-deficient mice (34). Furthermore, the histological find-
ings with HR6B-deficient testes are reminiscent of those ob-
served in PA200-deficient males (34). In this regard, HR6B-
deficient mice have a block in spermatogenesis with marked
defects in the maturation of haploid spermatids coupled with
the production of reduced numbers and grossly abnormal sper-
matozoa (34). Notably, the requirement for PA200 in spermat-
ogenesis is not shared by the PA28, -, or - proteasome
activators, as mice deficient in these proteins do not have
reported fertility defects (5, 25, 26, 32). Given this and the
isolated defects in spermatogenesis noted in both PA200- and
HR6B-deficient mice, it is tempting to speculate that spermat-
ogenesis poses unique protein metabolic challenges that are
met by specific nonredundant proteolytic pathways.
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